These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7773294)

  • 1. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
    Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA
    Nat Genet; 1995 Mar; 9(3):305-11. PubMed ID: 7773294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Donehower LA; Harvey M; Slagle BL; McArthur MJ; Montgomery CA; Butel JS; Bradley A
    Nature; 1992 Mar; 356(6366):215-21. PubMed ID: 1552940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
    Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
    Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generation and analyses of transgenic mice containing mutant p53 transgene].
    Hosokawa A
    Fukuoka Igaku Zasshi; 1999 Mar; 90(3):80-7. PubMed ID: 10339928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.
    Nishino H; Knöll A; Buettner VL; Frisk CS; Maruta Y; Haavik J; Sommer SS
    Oncogene; 1995 Jul; 11(2):263-70. PubMed ID: 7624143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice.
    Jenks PJ; Jeremy AH; Robinson PA; Walker MM; Crabtree JE
    J Pathol; 2003 Dec; 201(4):596-602. PubMed ID: 14648663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
    Harvey M; McArthur MJ; Montgomery CA; Butel JS; Bradley A; Donehower LA
    Nat Genet; 1993 Nov; 5(3):225-9. PubMed ID: 8275085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.
    Gao J; Huang HY; Pak J; Cheng J; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Oncogene; 2004 Jan; 23(3):687-96. PubMed ID: 14737103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protects against skin cancer induction by UV-B radiation.
    Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
    Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice.
    Ghebranious N; Sell S
    Hepatology; 1998 Apr; 27(4):967-73. PubMed ID: 9537435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
    French JE
    IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lim2(To3) transgenic mice establish a causative relationship between the mutation identified in the lim2 gene and cataractogenesis in the To3 mouse mutant.
    Steele EC; Wang JH; Lo WK; Saperstein DA; Li X; Church RL
    Mol Vis; 2000 Jun; 6():85-94. PubMed ID: 10851259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
    Harvey M; Sands AT; Weiss RS; Hegi ME; Wiseman RW; Pantazis P; Giovanella BC; Tainsky MA; Bradley A; Donehower LA
    Oncogene; 1993 Sep; 8(9):2457-67. PubMed ID: 8103211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
    Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T; Varmus HE; Donehower LA
    Cell Growth Differ; 1997 Aug; 8(8):829-38. PubMed ID: 9269892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.